The Financing of Drug Trials by Pharmaceutical Companies and Its Consequences: Part 2: A Qualitative, Systematic Review of the Literature on Possible Influences on Authorship, Access to Trial Data, and Trial Registration and Publication

類似資料

• The Financing of Drug Trials by Pharmaceutical Companies and Its Consequences: Part 1: A Qualitative, Systematic Review of the Literature on Possible Influences on the Findings, Protocols, and Quality of Drug Trials
  著者:: Schott, Gisela, 等
  出版事項: (2010)
• Does the Pharmaceutical Industry Influence Guidelines?: Two Examples From Germany
  著者:: Schott, Gisela, 等
  出版事項: (2013)
• Correspondence (reply): In Reply
  著者:: Lieb, Klaus, 等
  出版事項: (2010)
• Correspondence (reply): In Reply
  著者:: Schott, Gisela, 等
  出版事項: (2014)
• Declaration and Handling of Conflicts of Interest in Guidelines: A Study of S1 Guidelines From German Specialist Societies From 2010–2013
  著者:: Schott, Gisela, 等
  出版事項: (2015)